Hellinger Benjamin J, Remane Yvonne, Bertsche Thilo, Gries André
Klinikapotheke, Universitätsklinikum Leipzig AöR, Leipzig, Deutschland.
Abteilung für Klinische Pharmazie, Medizinische Fakultät, Universität Leipzig, Leipzig, Deutschland.
Anaesthesiologie. 2023 Dec;72(12):887-893. doi: 10.1007/s00101-023-01355-4. Epub 2023 Nov 17.
In a large proportion of patients admitted to the emergency department (ED), the initial main symptom is nonspecific. One possible reason for this, especially in older patients, may be adverse drug reactions (ADR) due to their frequent polypharmacy.
To illustrate the incidence of ADRs, the affected patient population including risk factors, and drug classes with ADRs leading to nonspecific symptoms. To provide practice recommendations for the management of ADRs in the ED.
Presentation of the pharmacological principles on ADRs, statistics of pharmacovigilance centers as well as original literature including experiences from clinical practice and own projects.
In 10% of patients with nonspecific symptoms an ADR is responsible for presentation in the ED. In 60% of cases these ADRs are not correctly identified in the ED setting. A small number of drug classes are responsible for most of these referrals. Databases, risk stratification, clinical pharmacists, or clinical decision support systems are available to improve ADR identification and management. As these options are partly associated with considerable costs or the validation for German EDs is missing, a widespread application does not take place.
Correct identification of ADRs in patients with nonspecific symptoms in the ED is necessary to initiate adequate treatment. These ADRs are often overlooked because processes and tools for identification and management are not applied in the ED, leading to a lack of awareness. For high-risk patients in the ED, the focus should be on drug history, ideally considering patient-specific risk factors and specific drug classes.
在急诊科(ED)收治的大部分患者中,初始主要症状是非特异性的。尤其是老年患者,出现这种情况的一个可能原因可能是频繁使用多种药物导致的药物不良反应(ADR)。
阐明ADR的发生率、受影响的患者群体(包括风险因素)以及导致非特异性症状的ADR相关药物类别。为急诊科ADR的管理提供实践建议。
介绍ADR的药理学原理、药物警戒中心的统计数据以及包括临床实践经验和自身项目的原始文献。
在10%有非特异性症状的患者中,ADR是其在急诊科就诊的原因。在60%的病例中,这些ADR在急诊科环境中未被正确识别。少数药物类别导致了这些转诊中的大部分。数据库、风险分层、临床药师或临床决策支持系统可用于改善ADR的识别和管理。由于这些选项部分与相当高的成本相关,或者德国急诊科缺乏验证,因此未能广泛应用。
在急诊科正确识别有非特异性症状患者的ADR对于启动适当治疗是必要的。这些ADR常常被忽视,因为急诊科未应用识别和管理的流程及工具,导致意识缺乏。对于急诊科的高危患者,应重点关注用药史,理想情况下考虑患者特定的风险因素和特定药物类别。